AU2014369774B2 - PRRS virus variant, European PRRS virus cDNA clone, and uses thereof - Google Patents

PRRS virus variant, European PRRS virus cDNA clone, and uses thereof Download PDF

Info

Publication number
AU2014369774B2
AU2014369774B2 AU2014369774A AU2014369774A AU2014369774B2 AU 2014369774 B2 AU2014369774 B2 AU 2014369774B2 AU 2014369774 A AU2014369774 A AU 2014369774A AU 2014369774 A AU2014369774 A AU 2014369774A AU 2014369774 B2 AU2014369774 B2 AU 2014369774B2
Authority
AU
Australia
Prior art keywords
virus
nucleic acid
seq
amino acid
prrs virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014369774A
Other languages
English (en)
Other versions
AU2014369774A1 (en
Inventor
Andreas GALLEI
Marieke HERREL
Christoph Keller
Erik SCHACHT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica GmbH filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of AU2014369774A1 publication Critical patent/AU2014369774A1/en
Application granted granted Critical
Publication of AU2014369774B2 publication Critical patent/AU2014369774B2/en
Priority to AU2021201224A priority Critical patent/AU2021201224B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/10011Arteriviridae
    • C12N2770/10041Use of virus, viral particle or viral elements as a vector
    • C12N2770/10043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2014369774A 2013-12-20 2014-12-19 PRRS virus variant, European PRRS virus cDNA clone, and uses thereof Active AU2014369774B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2021201224A AU2021201224B2 (en) 2013-12-20 2021-02-25 PRRS virus variant, European PRRS virus cDNA clone, and uses thereof

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13199177 2013-12-20
EP13199177.0 2013-12-20
EP14175691 2014-07-03
EP14175691.6 2014-07-03
PCT/EP2014/078929 WO2015092058A1 (en) 2013-12-20 2014-12-19 Prrs virus variant, european prrs virus cdna clone, and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2021201224A Division AU2021201224B2 (en) 2013-12-20 2021-02-25 PRRS virus variant, European PRRS virus cDNA clone, and uses thereof

Publications (2)

Publication Number Publication Date
AU2014369774A1 AU2014369774A1 (en) 2016-04-21
AU2014369774B2 true AU2014369774B2 (en) 2020-11-26

Family

ID=52347295

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2014369774A Active AU2014369774B2 (en) 2013-12-20 2014-12-19 PRRS virus variant, European PRRS virus cDNA clone, and uses thereof
AU2021201224A Active AU2021201224B2 (en) 2013-12-20 2021-02-25 PRRS virus variant, European PRRS virus cDNA clone, and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2021201224A Active AU2021201224B2 (en) 2013-12-20 2021-02-25 PRRS virus variant, European PRRS virus cDNA clone, and uses thereof

Country Status (13)

Country Link
US (2) US10010601B2 (enExample)
EP (2) EP3591042B1 (enExample)
JP (3) JP6886291B2 (enExample)
KR (2) KR102270344B1 (enExample)
CN (1) CN105829528B (enExample)
AU (2) AU2014369774B2 (enExample)
CA (1) CA2930042C (enExample)
DK (2) DK3083947T3 (enExample)
EA (1) EA039060B1 (enExample)
ES (2) ES2729838T3 (enExample)
HU (1) HUE061768T2 (enExample)
MX (2) MX375528B (enExample)
WO (1) WO2015092058A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103370077B (zh) 2011-02-17 2016-10-26 贝林格尔.英格海姆维特梅迪卡有限公司 猪繁殖与呼吸综合征病毒的商业化规模生产方法
SG192820A1 (en) 2011-02-17 2013-09-30 Boehringer Ingelheim Vetmed Novel european prrsv strain
MX375528B (es) * 2013-12-20 2025-03-06 Boehringer Ingelheim Vetmedica Gmbh Variante del virus prrs, clon de adnc del virus europeo y sus usos.
WO2018024677A1 (en) 2016-08-05 2018-02-08 Hipra Scientific, S.L.U. PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS cDNA CLONE AND USES THEREOF
WO2020138761A1 (ko) * 2018-12-27 2020-07-02 주식회사 바이오포아 돼지 생식기 및 호흡기 증후군 바이러스의 키메라 바이러스 및 이를 이용한 백신
KR102335864B1 (ko) * 2018-12-27 2021-12-06 주식회사 바이오포아 돼지 생식기 및 호흡기 증후군 바이러스의 키메라 바이러스 및 이를 이용한 백신
US12214032B2 (en) 2019-08-29 2025-02-04 Elanco Uk Ah Limited Porcine Reproductive and Respiratory Syndrome vaccine virus
CN110894243B (zh) * 2019-12-16 2021-07-13 中国农业大学 一种猪蓝耳病毒嵌合抗原以及检测猪蓝耳病毒抗体的胶体金免疫层析试纸条
EP4085130A4 (en) * 2019-12-31 2024-04-10 Elixirgen Therapeutics, Inc. TEMPERATURE-BASED TRANSIENT DELIVERY OF NUCLEIC ACIDS AND PROTEINS TO CELLS AND TISSUES
JP2021153692A (ja) * 2020-03-25 2021-10-07 株式会社三共 遊技機
KR102319508B1 (ko) * 2020-07-27 2021-10-28 연세대학교 산학협력단 인체 감염형 낙타 유래 메르스코로나바이러스 검출용 바이오마커 및 이의 용도
CN113969267B (zh) * 2021-11-15 2024-02-27 中国农业大学 一种猪繁殖与呼吸综合征突变病毒及其构建方法与应用
WO2024077281A2 (en) * 2022-10-06 2024-04-11 Cornell University Genotyping and sequencing assays for prrsv
KR20240146158A (ko) * 2023-03-27 2024-10-08 주식회사 케어사이드 돼지생식기호흡기증후군 키메릭 바이러스 및 이를 이용한 백신 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1018557A2 (en) * 1998-12-22 2000-07-12 Pfizer Products Inc. Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137631A (en) 1959-12-01 1964-06-16 Faberge Inc Encapsulation in natural products
US3959457A (en) 1970-06-05 1976-05-25 Temple University Microparticulate material and method of making such material
US4015100A (en) 1974-01-07 1977-03-29 Avco Everett Research Laboratory, Inc. Surface modification
EP0000062A1 (en) 1977-06-07 1978-12-20 Joseph George Spitzer Vapor tap valve for aerosol containers used with inflammable propellants, and container provided therewith
US4205060A (en) 1978-12-20 1980-05-27 Pennwalt Corporation Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use
DE3687769T2 (de) 1985-07-08 1993-09-02 Chiron Corp Vakzine und diagnostika, die vom bovine-diarrhea-virus stammen.
NZ222465A (en) 1986-11-07 1992-11-25 Pasteur Institut Nanb (non a, non b hepatitis viral) antigen
CA2103460C (en) 1991-06-06 2000-09-26 Gert Wensvoort Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
US6042830A (en) 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
DK0610250T4 (da) 1991-10-14 2009-03-02 Intervet Int Bv Vaccine med porcint reproduktivt respiratorisk syndrom (PRRS) og diagnose heraf
FR2686097B1 (fr) 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5695766A (en) 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
ES2074950B1 (es) 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
DK0676467T3 (da) 1994-04-11 2002-01-21 Akzo Nobel Nv Europæiske vaccinestammer af det porcine reproduktive respiratoriske syndromvirus (PRRSV)
GB2289279B (en) 1994-05-13 1998-09-16 Iberica Cyanamid Diagnostic kits and vaccines containing recombinant PRRSV proteins
ES2223058T3 (es) 1995-03-14 2005-02-16 Akzo Nobel N.V. Expresion en la misma celula de polipeptidos del virus del sindrome reproductivo y respiratorio porcino.
ES2102971B1 (es) 1996-01-25 1998-03-01 Hipra Lab Sa Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
US5866401A (en) 1996-03-01 1999-02-02 Schering Corporation Porcine reproductive and respiratory syndrome vaccine
PT835930E (pt) 1996-10-09 2001-06-29 Akzo Nobel Nv Estirpes europeias de vacina do virus do sindroma reprodutivo e respiratorio porcino (prrsv)
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
US20040224327A1 (en) 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
WO2000053787A1 (en) 1999-03-08 2000-09-14 Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. Prrsv vaccines
SK286063B6 (sk) 1997-05-06 2008-02-05 Boehringer Ingelheim Vetmedica Gmbh Peptid vyvolávajúci tvorbu protilátok, protilátkareaktívna s týmto peptidom a diagnostická súpravaobsahujúca peptid a protilátku
EP2251419B1 (en) 1999-04-22 2012-05-30 United States Department of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142
DE60121545T2 (de) 2000-02-08 2007-06-28 Regents Of The University Of Minnesota, Minneapolis Virus des porcinen reproduktiven und respiratorischen syndroms und dessen verwendung
EP1156111A1 (en) 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Chimeric arterivirus-like particles
EP1397498A1 (en) 2001-05-21 2004-03-17 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Delections in arterivirus replicons
ATE557082T1 (de) 2002-04-05 2012-05-15 Boehringer Ingelheim Vetmed Sequenz positionen zur anpassung bei prrsv
US7722878B2 (en) 2004-06-17 2010-05-25 Boehringer Ingelheim Vetmedica, Inc. PRRSV subunit vaccines
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
ATE462445T1 (de) 2005-01-13 2010-04-15 Boehringer Ingelheim Vetmed Prrs-impfstoffe
WO2008121958A1 (en) 2007-04-02 2008-10-09 Boehringer Ingelheim Vetmedica, Inc. Use of prrsv vaccines to reduce pcv2 viremia
EP2181189B1 (en) * 2007-06-25 2012-06-20 South Dakota State University Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use
WO2010025109A1 (en) 2008-08-25 2010-03-04 Boehringer Ingelheim Vetmedia, Inc. Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs)
US20120013810A1 (en) * 2009-01-20 2012-01-19 Sharp Kabushiki Kaisha Lighting device, display device and television receiver
ES2742262T3 (es) 2010-04-16 2020-02-13 Univ Gent Vacuna con protección cruzada para el virus del síndrome respiratorio y reproductivo porcino
CN103370077B (zh) 2011-02-17 2016-10-26 贝林格尔.英格海姆维特梅迪卡有限公司 猪繁殖与呼吸综合征病毒的商业化规模生产方法
SG192820A1 (en) 2011-02-17 2013-09-30 Boehringer Ingelheim Vetmed Novel european prrsv strain
EP2737058A1 (en) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
US9567606B2 (en) * 2012-02-14 2017-02-14 Merial Inc. Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
CN104302316A (zh) * 2012-05-17 2015-01-21 佐蒂斯有限责任公司 在断奶之前对抗猪繁殖与呼吸综合征(prrs)病毒的有效疫苗接种
CN105073130A (zh) 2013-03-15 2015-11-18 勃林格殷格翰动物保健公司 猪生殖与呼吸综合征病毒、组合物、疫苗及使用方法
CN105829906B (zh) * 2013-12-19 2020-11-03 皇家飞利浦有限公司 具有水/脂肪分离的相位敏感的反转恢复mri
MX375528B (es) * 2013-12-20 2025-03-06 Boehringer Ingelheim Vetmedica Gmbh Variante del virus prrs, clon de adnc del virus europeo y sus usos.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1018557A2 (en) * 1998-12-22 2000-07-12 Pfizer Products Inc. Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PRIETO C ET AL, "Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred", VETERINARY JOURNAL, 2008, 175(3):356-363 *

Also Published As

Publication number Publication date
JP2020054380A (ja) 2020-04-09
JP2017502662A (ja) 2017-01-26
WO2015092058A1 (en) 2015-06-25
CN105829528A (zh) 2016-08-03
JP7158523B2 (ja) 2022-10-21
KR102270344B1 (ko) 2021-07-01
ES2729838T3 (es) 2019-11-06
EA039060B1 (ru) 2021-11-29
KR20160099099A (ko) 2016-08-19
KR20210080606A (ko) 2021-06-30
DK3591042T5 (da) 2024-09-02
MX2016007737A (es) 2016-09-07
CN105829528B (zh) 2019-10-22
US10639364B2 (en) 2020-05-05
AU2021201224B2 (en) 2023-06-15
EP3083947A1 (en) 2016-10-26
CA2930042C (en) 2022-06-21
US20190151432A1 (en) 2019-05-23
AU2014369774A1 (en) 2016-04-21
MX375528B (es) 2025-03-06
US20160317642A1 (en) 2016-11-03
US10010601B2 (en) 2018-07-03
HUE061768T2 (hu) 2023-08-28
DK3083947T3 (da) 2019-07-08
EP3591042A1 (en) 2020-01-08
JP6886291B2 (ja) 2021-06-16
KR102446025B1 (ko) 2022-09-22
AU2021201224A1 (en) 2021-03-11
EP3591042B1 (en) 2023-01-25
MX2020010248A (es) 2020-10-16
EA201600476A1 (ru) 2016-11-30
JP2021104028A (ja) 2021-07-26
EP3083947B1 (en) 2019-04-03
DK3591042T3 (da) 2023-04-17
CA2930042A1 (en) 2015-06-25
ES2940691T3 (es) 2023-05-10

Similar Documents

Publication Publication Date Title
AU2021201224B2 (en) PRRS virus variant, European PRRS virus cDNA clone, and uses thereof
US9187731B2 (en) PRRS virus inducing type I interferon in susceptible cells
JP2018030869A (ja) ブタ生殖および呼吸症候群(prrs)ウイルスに対する離乳前の効果的なワクチン接種
KR101321153B1 (ko) Prrs 바이러스, 감염성 클론, 그의 돌연변이체, 및사용 방법
US20040009190A1 (en) Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
US20140314808A1 (en) Infectious cdna clone of european prrs virus and uses thereof
JP2004534522A (ja) 生きた弱毒化されたprrsウイルス株
KR20170002393A (ko) 비자연적으로 발생하는 돼지생식기호흡기증후군 바이러스 및 사용방법
TW201319083A (zh) 於易感細胞內誘發第i型干擾素之新穎prrs病毒
EA044385B1 (ru) Вариант вируса ррсс, клон кднк вируса ррсс европейского типа и их применение
AU2002256653A1 (en) Life attenuated strains of PRRS virus

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)